Delay in the fetal globin switch in infants of diabetic mothers.
In the normal fetus, a switch from production of hemoglobin F (alpha 2 gamma 2) to hemoglobin A (alpha 2 beta 2) occurs at 28 to 34 weeks of gestation. In the fetus with beta-hemoglobinopathy or beta-thalassemia, this switch proceeds despite the morbidity that results when production of beta-globin is abnormal or reduced. Since insulin has recently been shown to induce renewed expression of some inactive genes, we studied globin biosynthesis during the natural evolution of the fetal globin switch under conditions of hyperinsulinemia, which occurs in infants of diabetic mothers. Such infants develop in a hyperglycemic environment, which produces reactive hyperinsulinemia. The normal increase in beta-globin production from pre-switch levels did not occur in 9 of 10 such infants at term, as compared with 11 normal infants, in whom the switch occurred by 36 to 39 weeks of gestation (P less than 0.0001). The delay in the switch from gamma-globin to beta-globin in this unique clinical setting may allow identification of physiologic factors that can modulate developmental gene suppression.
Perrine
S P
SP
Greene
M F
MF
Faller
D V
DV
D004921:Erythropoietin / Q000032:analysis; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D005319:Fetal Hemoglobin / Q000096:biosynthesis; D005333:Fetus / Q000378:metabolism*; D005786:Gene Expression Regulation; D005865:Gestational Age; D005914:Globins / Q000096:biosynthesis* / Q000235:genetics; D006441:Hemoglobin A / Q000096:biosynthesis; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000097:blood; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000097:blood
D007328:Insulin; D004921:Erythropoietin; D005914:Globins; D006441:Hemoglobin A; D005319:Fetal Hemoglobin